175 related articles for article (PubMed ID: 37291688)
21. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States.
Huang KP; Mullangi S; Guo Y; Qureshi AA
JAMA Dermatol; 2013 Jul; 149(7):789-94. PubMed ID: 23700152
[TBL] [Abstract][Full Text] [Related]
22. Pediatric Alopecia Areata.
Afford R; Leung AKC; Lam JM
Curr Pediatr Rev; 2021; 17(1):45-54. PubMed ID: 32351186
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and prognostic factors in early-onset alopecia totalis and alopecia universalis.
Cho HH; Jo SJ; Paik SH; Jeon HC; Kim KH; Eun HC; Kwon OS
J Korean Med Sci; 2012 Jul; 27(7):799-802. PubMed ID: 22787378
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.
Lee HH; Gwillim E; Patel KR; Hua T; Rastogi S; Ibler E; Silverberg JI
J Am Acad Dermatol; 2020 Mar; 82(3):675-682. PubMed ID: 31437543
[TBL] [Abstract][Full Text] [Related]
25. Alopecia areata in Tunisia: epidemio-clinical aspects and comorbid conditions. A prospective study of 204 cases.
Arousse A; Boussofara L; Mokni S; Gammoudi R; Saidi W; Aounallah A; Belajouza C; Ghariani N; Denguezli M; Nouira R
Int J Dermatol; 2019 Jul; 58(7):811-815. PubMed ID: 30677128
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review.
Liu LY; King BA; Craiglow BG
J Am Acad Dermatol; 2016 Oct; 75(4):806-812.e3. PubMed ID: 27436156
[TBL] [Abstract][Full Text] [Related]
27. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history.
Goh C; Finkel M; Christos PJ; Sinha AA
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1055-60. PubMed ID: 16987257
[TBL] [Abstract][Full Text] [Related]
28. Severe subtype of alopecia areata is highly associated with thyroid autoimmunity.
Bin Saif GA
Saudi Med J; 2016 Jun; 37(6):656-61. PubMed ID: 27279512
[TBL] [Abstract][Full Text] [Related]
29. Comorbidities in pediatric alopecia areata.
Conic RZ; Tamashunas NL; Damiani G; Fabbrocini G; Cantelli M; ; Bergfeld WF
J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2898-2901. PubMed ID: 32531131
[TBL] [Abstract][Full Text] [Related]
30. Global, regional and national burden of alopecia areata and its associated diseases, 1990-2019: A systematic analysis of the Global Burden of Disease Study 2019.
Jang H; Park S; Kim MS; Yon DK; Lee SW; Koyanagi A; Kostev K; Shin JI; Smith L
Eur J Clin Invest; 2023 Jun; 53(6):e13958. PubMed ID: 36692126
[TBL] [Abstract][Full Text] [Related]
31. Association of alopecia areata with atopic dermatitis and chronic spontaneous urticaria.
Magen E; Chikovani T; Waitman DA; Kahan NR
Allergy Asthma Proc; 2018 Mar; 39(2):96-102. PubMed ID: 29490767
[TBL] [Abstract][Full Text] [Related]
32. Time-Dependent Risk of Acute Myocardial Infarction in Patients With Alopecia Areata in Korea.
Shin JW; Kang T; Lee JS; Kang MJ; Huh CH; Kim MS; Kim HJ; Ahn HS
JAMA Dermatol; 2020 Jul; 156(7):763-771. PubMed ID: 32401269
[TBL] [Abstract][Full Text] [Related]
33. Familial implications of autoimmune disease: Recurrence risks of alopecia areata and associated conditions in first-degree relatives.
Agre K; McCarthy Veach P; Bemmels H; Wiens K; LeRoy BS; Hordinsky M
J Genet Couns; 2020 Feb; 29(1):35-43. PubMed ID: 31605426
[TBL] [Abstract][Full Text] [Related]
34. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study.
Chu SY; Chen YJ; Tseng WC; Lin MW; Chen TJ; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
J Am Acad Dermatol; 2011 Nov; 65(5):949-56. PubMed ID: 21616562
[TBL] [Abstract][Full Text] [Related]
35. Association of Vitiligo and Alopecia Areata With Atopic Dermatitis: A Systematic Review and Meta-analysis.
Mohan GC; Silverberg JI
JAMA Dermatol; 2015 May; 151(5):522-8. PubMed ID: 25471826
[TBL] [Abstract][Full Text] [Related]
36. The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care.
Macbeth AE; Holmes S; Harries M; Chiu WS; Tziotzios C; de Lusignan S; Messenger AG; Thompson AR
Br J Dermatol; 2022 Jul; 187(1):73-81. PubMed ID: 35157313
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.
Kennedy Crispin M; Ko JM; Craiglow BG; Li S; Shankar G; Urban JR; Chen JC; Cerise JE; Jabbari A; Winge MC; Marinkovich MP; Christiano AM; Oro AE; King BA
JCI Insight; 2016 Sep; 1(15):e89776. PubMed ID: 27699252
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Prevalence and Incidence of Pediatric Alopecia Areata Using Electronic Health Record Data.
McKenzie PL; Maltenfort M; Bruckner AL; Gupta D; Harfmann KL; Hyde P; Forrest CB; Castelo-Soccio L
JAMA Dermatol; 2022 May; 158(5):547-551. PubMed ID: 35385065
[TBL] [Abstract][Full Text] [Related]
39. Alopecia areata is not a risk factor for heart diseases: A 10-year retrospective cohort study.
Lee H; Kim YC; Choi JW
PLoS One; 2021; 16(5):e0250216. PubMed ID: 33961663
[TBL] [Abstract][Full Text] [Related]
40. Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis.
Done N; Bartolome L; Swallow E; Gao W; Carley C; Wang T; Mostaghimi A
Acta Derm Venereol; 2023 Aug; 103():adv12445. PubMed ID: 37622204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
